Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2026)

Adaptive Biotechnologies has reported Change in Inventory for 9 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Change in Inventory rose 598.11% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 156.95% YoY) and the FY2025 annual result came in at $998000.0, up 118.58% from the prior year.
• Change in Inventory grew to $1.3 million in Q1 2026 per ADPT's latest filing, from $10000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $6.6 million in Q1 2023 and troughed at -$4.0 million in Q4 2023.
• A 5-year average of -$61058.8 and a median of -$65000.0 in 2023 frame the typical range for Change in Inventory.
• The widest YoY moves for Change in Inventory: up 1358.46% in 2024, down 721.61% in 2024.
• Over 5 years, Change in Inventory stood at -$3.0 million in 2022, then slumped by 31.3% to -$4.0 million in 2023, then climbed by 14.96% to -$3.4 million in 2024, then soared by 100.3% to $10000.0 in 2025, then surged by 13050.0% to $1.3 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $1.3 million, $10000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.